REDHILL BIOPHARMA LTD. Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2022-12-27: Form 6-K/A; Period of report 2022-12-27; Description 6-K/A; Document zk2228920.htm.
- 2022-12-20: Form 6-K; Period of report 2022-12-20; Description 6-K; Document zk2228903.htm.
- 2022-12-12: Form 6-K; Period of report 2022-12-12; Description 6-K; Document zk2228876.htm.
- 2022-12-06: Form 6-K; Period of report 2022-12-06; Description 6-K; Document zk2228860.htm.